Stay updated on CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial
Sign up to get notified when there's something new on the CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial page.

Latest updates to the CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial page
- Check4 days agoChange DetectedThe study record for a Phase 3 guselkumab trial in generalized pustular or erythrodermic psoriasis is displayed, with details on study methods, eligibility, measured outcomes, and its completed status.SummaryDifference46%

- Check11 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedA banner announces NIH website updates and says that some content may use “Super Intelligence” (SI) instead of “Artificial Intelligence” (AI) during the transition.SummaryDifference1%

- Check25 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2. The page continues to display a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe revision identifier in the footer changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check53 days agoChange DetectedRevision: v3.7.0 is now shown on the page, indicating an update to the page template and related metadata.SummaryDifference16%

Stay in the know with updates to CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial page.